works as a Senior Scientist at Egis Pharmaceu¬ticals PLC, Budapest, Hungary with a focus towards development of platform and other emerging technologies in innovative and complex generic formulations. Before Egis, he worked at Dr. Reddy’s Laboratories, India. He has served as a Scientist at IPCA laboratories, Macleods Pharmaceuticals and Alkem laboratories, India. He has 11 years of experience in drug products development, using different approaches and various technologies which include hot melt extrusion (HME), gastro-retentive drug delivery systems, and nanotechnology and cyclodextrin complexation. He is an expert in materializing the design of experiments (DOE) and quality by design (QBD). He obtained his MPharm and PhD in Pharmaceutics from Indian Institute of Technology, Banaras Hindu University, India. He has five patents and published eight peer-reviewed papers in reputed national and international journals. He has attended and presented his research work at various national and international conferences.  works as a Senior Scientist at Egis Pharmaceu¬ticals PLC, Budapest, Hungary with a focus towards development of platform and other emerging technologies in innovative and complex generic formulations. Before Egis, he worked at Dr. Reddy’s Laboratories, India. He has served as a Scientist at IPCA laboratories, Macleods Pharmaceuticals and Alkem laboratories, India. He has 11 years of experience in drug products development, using different approaches and various technologies which include hot melt extrusion (HME), gastro-retentive drug delivery systems, and nanotechnology and cyclodextrin complexation. He is an expert in materializing the design of experiments (DOE) and quality by design (QBD). He obtained his MPharm and PhD in Pharmaceutics from Indian Institute of Technology, Banaras Hindu University, India. He has five patents and published eight peer-reviewed papers in reputed national and international journals. He has attended and presented his research work at various national and international conferences.

focus towards development of platform and other emerging technologies in innovative and complex generic formulations